BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10083538)

  • 1. Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat.
    Jiang H; Yang XF; Soriano R; Fujitsu T; Kobayashi M
    Transplant Proc; 1999; 31(1-2):1203-5. PubMed ID: 10083538
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration.
    Ebbs A; Pan F; Wynn C; Erickson L; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1378-81. PubMed ID: 12176404
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

  • 5. IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection.
    Jiang H; Yang XF; Wynn C; Soriano R; Krishnan K; Fujimura T; Kobayashi M
    Transplant Proc; 2001; 33(1-2):510-3. PubMed ID: 11266931
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection.
    Walgenbach KJ; Llull R; Murase N; Starzl TE; Hirner A
    Transplant Proc; 1997; 29(1-2):1542. PubMed ID: 9123418
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2191-2. PubMed ID: 11377499
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression.
    Erickson L; Crews G; Pan F; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1385-6. PubMed ID: 12176407
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
    Little DM; Stoltenberg RL; Hullett DA; Sollinger HW
    Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute rejection of rat renal allografts is influenced by the presence of a native kidney.
    Grau V; Herbst B; Steiniger B
    Transplant Proc; 1997 May; 29(3):1723. PubMed ID: 9142247
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat.
    Soots A; Lautenschlager I; Krogerus L; Saarinen O; Ahonen J
    Transplant Proc; 1997 Nov; 29(7):3152. PubMed ID: 9365704
    [No Abstract]   [Full Text] [Related]  

  • 14. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
    Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
    Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
    Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
    Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication.
    Wynn C; Pan F; Erickson L; Ebbs A; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1387-9. PubMed ID: 12176408
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.